SNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month – Ebola Vaccine Optimism Fuels Retail Frenzy

Soligenix shares are also poised to break above the 100-day moving average for the first time in a month, following a ...
Opinion

A New Hantavirus Vaccine Is in the Works

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

Bundibugyo Ebola vaccines and treatments in development

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...
STAT

With no approved vaccine for Ebola outbreak, experts weigh testing a long shot

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.
The Scientist

Slowed But Not Stalled: The Future of mRNA Vaccine Research

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...
Forbes

Immunization: How It Started, How It’s Going – What We’ve Achieved Through 50 Years Of Vaccination Programs

Immunization is one of the most effective health interventions we can make. Every year vaccination programmes save millions of lives. They have helped eradicate diseases like smallpox – a deadly ...
GlobalData on MSN

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

Under the agreement, VECOL will act as the primary implementing partner while SK bioscience contributes technology transfer ...